3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow ACT-709478: new trials by email Literature Review of ACT-709478 trials Research Report on ACT-709478
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare a Single-dose of Two Different Formulations of ACT-709478 in Healthy Men ACT-709478 - Healthy Subjects | Phase 1 | Completed | Idorsia Pharmaceuticals Ltd. | 20 | 2019-12-16 | 2020-02-25 |
| A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients ACT-709478 for oral use, Placebo - Photosensitive Epilepsy | Phase 2 | Completed | Idorsia Pharmaceuticals Ltd. | 5 | 2017-10-06 | 2018-08-31 |
| Study to Evaluate Safety and Tolerability of ACT-709478 in Healthy Subjects ACT-709478, Placebo, Midazolam - Healthy Subjects | Phase 1 | Completed | Idorsia Pharmaceuticals Ltd. | 46 | 2017-07-07 | 2019-12-24 |
Epilepsy, Reflex (1)
Idorsia Pharmaceuticals Ltd. (3)
Germany (2) · Czechia (1) · France (1)
2017 (1), 2019 (1)